Life sciences companies tend to consider themselves leaders when it comes to compliance policies.

In one sense they're right. The close sales relations between their distribution agents and state-linked doctors and hospitals have lo...

Sometimes even the gold standard still isn't enough. Since 1995, company leaders and their corporate counsel have leaned on a single, well-respected measure to gauge vulnerability to bribery and corruption risks around th...

Not that long ago, the process for filling orders or assembling a product involved mind-numbing tasks done over and over again, to the point the worker really didn't have to think.

Building a car, for instance, was essentially a han...

Typically, working with higher-risk third parties can creep up on a company that is either high growth or in a more regulated industry.

In the earlier part of their growth stories, most companies essentially wing it when it comes to...

As global M&A activity surges again after a brief Covid-19-related slump, it's a sure bet some acquiring companies will be inheriting unpleasant surprises along with their new partners.

One of the most underrated acquisition per...

For the past eight months, my company has been on the receiving end of a different kind of censorship from America's Big Tech companies. But not for any of the headline-generating reasons Donald Trump or Parler have been shut down. We've been...